75834-230 : Remifentanil Hydrochloride 1 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 75834-230
Labeler: Nivagen Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Remifentanil Hydrochloride
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA215635
Rev. Date: 
CSA Schedule: CII (US) [1]


[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 75834-230-10: 10 VIAL, GLASS IN 1 CARTON (75834‑230‑10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, GLASS (75834‑230‑01)

Active Ingredients:

  • Remifentanil Hydrochloride

Dosage Strength:

  • 1 mg

Pharmaceutical Classes:

  • Full Opioid Agonists [MoA]
  • Opioid Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 75834-231 Remifentanil Hydrochloride 2 mg Intravenous Injection, Powder, Lyophilized, for Solution by Nivagen Pharmaceuticals, Inc.
  • 75834-232 Remifentanil Hydrochloride 5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Nivagen Pharmaceuticals, Inc.
  • 0143-9391 Remifentanil Hydrochloride 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9392 Remifentanil Hydrochloride 2 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9393 Remifentanil Hydrochloride 5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 63323-723 Remifentanil Hydrochloride 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 63323-724 Remifentanil Hydrochloride 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 63323-725 Remifentanil Hydrochloride 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 68475-505 Remifentanil Hydrochloride 1 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Navinta LLC
  • 68475-506 Remifentanil Hydrochloride 2 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Navinta LLC
  • 68475-507 Remifentanil Hydrochloride 5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Navinta LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 75834-230 QR Code

< Prev: 75834-226Next: 75834-231 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.